(Q54903549)

English

M233

cell line

In more languages

Statements

1 reference

Cellosaurus release 44

23 January 2023

cancer cell line

1 reference

Cellosaurus release 44

23 January 2023

described by source

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.

1 reference

Cellosaurus release 44

23 January 2023

Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma

1 reference

Cellosaurus release 44

23 January 2023

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

1 reference

Cellosaurus release 44

23 January 2023

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

1 reference

Cellosaurus release 44

23 January 2023

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma

1 reference

Cellosaurus release 44

23 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 44

23 January 2023

Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance

1 reference

Cellosaurus release 44

23 January 2023

established from medical condition

1 reference

Cellosaurus release 44

23 January 2023

derived from organism type

unknown value

1 reference

Cellosaurus release 44

23 January 2023

Identifiers

1 reference

Cellosaurus release 44

23 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54903549&oldid=1861543580"